Universities and research organizations filed nearly as many patent applications as corporations for COVID-19 vaccines during the early months of the global pandemic, with China and U.S.-based innovators most actively patenting new anti-COVID19 vaccine and therapeutic technologies, according to a WIPO report on pandemic-era innovation trends.
10 марта 2022 г. | ВОИС В центре внимания